Inventor · disambiguated record
James Herrmann
Also filed as: HERRMANN JAMES · HERRMANN JAMES J
6 granted patents·4 pending applications·120 citations·filing 2002–2022
81Inventor score
Top patents by PatentIndex Score
10 records- 0193USD472637SEye disease screening instrumentWELCH ALLYN INC·Filed 2002·Granted Apr 1, 2003·103 cites·1 claims
- 0287US8722049B2Antibody and methods for selective inhibition of T-cell responsesTOLERA THERAPEUTICS INC·Filed 2013·Granted May 13, 2014·6 cites·7 claims
- 0386US11510996B2Covalent polymer-antigen conjugated particlesCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2016·Granted Nov 29, 2022·3 cites·18 claims
- 0484US8524234B2Antibody for selective inhibition of T-cell responsesTOLERA THERAPEUTICS INC·Filed 2012·Granted Sep 3, 2013·8 cites·2 claims
- 0573US12502436B2Covalent polymer-antigen conjugated particlesCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2022·Granted Dec 23, 2025·0 cites·20 claims
- 0657US8968739B2Antibody and methods for selective inhibition of T-cell responsesTOLERA THERAPEUTICS INC·Filed 2013·Granted Mar 3, 2015·0 cites·6 claims
- 0755US2013273089A1Antibody and methods for selective inhibition of t-cell responsesTOLERA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 0851US2024197866A1Treatment of peanut allergy with tolerizing nanoparticlesCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2022·Application pending·0 cites
- 0950US2024201187A1Method of Tracking Maintenance of Immunological ToleranceCOUR PHARMACEUTICALS DEV COMPANY INC·Filed 2022·Application pending·0 cites
- 1043US2015252109A1Antibody and methods for selective inhibition of t-cell responsesTOLERA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →